HLA-DRA and adenocarcinoma: Samuels et al. compared cervical squamous cell and cervical adenocarcinomas and found that HLA-DRA was expressed in 68.3% of squamous cell tumors and 93.8% of adenocarcinoma tumors and was associated with increased disease-free survival [56].